Jacques Reynes

14.6k total citations · 2 hit papers
207 papers, 8.1k citations indexed

About

Jacques Reynes is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Jacques Reynes has authored 207 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Infectious Diseases, 100 papers in Virology and 57 papers in Epidemiology. Recurrent topics in Jacques Reynes's work include HIV Research and Treatment (100 papers), HIV/AIDS drug development and treatment (85 papers) and HIV/AIDS Research and Interventions (53 papers). Jacques Reynes is often cited by papers focused on HIV Research and Treatment (100 papers), HIV/AIDS drug development and treatment (85 papers) and HIV/AIDS Research and Interventions (53 papers). Jacques Reynes collaborates with scholars based in France, United States and Spain. Jacques Reynes's co-authors include Pierre Corbeau, Vincent Baillat, Brigitte Montès, Monsef Benkirane, Michel Segondy, Éric Delaporte, M. Mallié, Hans-Jürgen Stellbrink, Yea‐Lih Lin and Christine Katlama and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jacques Reynes

203 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suppression of MicroRNA-Silencing Pathway by HIV-1 During Virus Replication

2007 516 citations Robinson Triboulet, Bernard Mari et al. Science profile →
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

2017 278 citations Jacques Reynes, Kirsten White et al. The Lancet profile →

Peers

Countries citing papers authored by Jacques Reynes

Since Specialization

Citations

This map shows the geographic impact of Jacques Reynes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Reynes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Reynes more than expected).

Fields of papers citing papers by Jacques Reynes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Reynes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Reynes. The network helps show where Jacques Reynes may publish in the future.

Co-authorship network of co-authors of Jacques Reynes

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Reynes. A scholar is included among the top collaborators of Jacques Reynes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Reynes. Jacques Reynes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Antibiotic Exposure on Staphylococcus epidermidis Responsible for Catheter-Related Bacteremia 2023 ·International Journal of Molecular Sciences ·Cassandra Pouget, C. Chatre, Jean‐Philippe Lavigne, Alix Pantel, Jacques Reynes, Catherine Dunyach‐Remy	10
2	Post‐exposure prophylaxis completion and condom use in the context of potential sexual exposure to HIV* 2020 ·HIV Medicine ·Pierre Gantner, Clotilde Allavena, Claudine Duvivier, André Cabié, Jacques Reynes, Alain Makinson, Isabelle Ravaux, Sylvie Brégigeon, Laurent Cotte, D. Rey, (unknown)	4
3	Efficacy of dual therapy with protease inhibitors plus lamivudine as maintenance treatment in HIV-positive patients on second line in Africa : the ANRS 12286/MOBIDIP trial 96-week results 2017 ·Journal of the International AIDS Society ·Laura Ciaffi, (unknown), (unknown), (unknown), Sabrina Eymard‐Duvernay, Suzanne Izard, Vincent Le Moing, Jacques Zoungrana, (unknown), Charles Kouanfack, (unknown), Ndèye Fatou Ngom Gueye, (unknown), Guillaume Bado, Katie Kane, Avelin F. Aghokeng, Martine Peeters, Jacques Reynes, Éric Delaporte	1
4	HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study 2017 ·Journal of Antimicrobial Chemotherapy ·Charlotte Charpentier, Brigitte Montès, Marine Perrier, (unknown), Jacques Reynes	33
5	Dual therapy with a boosted protease inhibitor plus lamivudine is an effective maintenance strategy in patients on second-line antiretroviral therapy in Africa : the ANRS 12286/MOBIDIP trial 2016 ·Journal of the International AIDS Society ·Laura Ciaffi, Sinata Koulla‐Shiro, (unknown), Ndèye Fatou Ngom Gueye, Vincent Le Moing, Sabrina Eymard‐Duvernay, Suzanne Izard, Jacques Zoungrana, (unknown), (unknown), Guillaume Bado, Katie Kane, Avelin F. Aghokeng, Martine Peeters, Jacques Reynes, Éric Delaporte	2
6	Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial 2014 ·The Lancet Infectious Diseases ·José Ramón Arribas, Gilles Pialoux, Joseph Gathe, Giovanni Di Perri, Jacques Reynes, Pablo Tebas, (unknown), Ramin Ebrahimi, Kirsten White, David Piontkowsky	89
7	Comparison of EBV DNA viral load in whole blood, plasma, B‐cells and B‐cell culture supernatant 2013 ·Journal of Medical Virology ·(unknown), Karine Bolloré, Johannes Viljoen, Vincent Foulongne, Jacques Reynes, Guillaume Cartron, (unknown), Philippe Van de Perre, Édouard Tuaillon	18
8	Maraviroc Intensification of Stable Antiviral Therapy in HIV-1–Infected Patients With Poor Immune Restoration 2012 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Lise Cuzin, (unknown), Pierre Delobel, (unknown), Jacques Reynes, Clotilde Allavena, Gilles Peytavin, Jade Ghosn, Caroline Lascoux‐Combe, Christina Psomas, Pierre Corbeau, Philippe Flandre	33
9	Impact on Health-Related Quality of Life of a Switch From Enfuvirtide to Raltegravir Among Multidrug-Resistant HIV-1–Infected Patients: A Randomized Open-Label Trial (EASIER-ANRS 138) 2010 ·HIV Clinical Trials ·Thomas Boulet, Juliette Pavie, Isabelle Charreau, Joséphine Braun, Jacques Reynes, Philippe Morlat, Lionel Piroth, Bruno Spire, Jean‐Michel Molina, J Aboulker	8
10	The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy* 2010 ·HIV Medicine ·DA Cooper, (unknown), Peter Reiss, Keith Henry, Mark Nelson, Mary O’Hearn, Jacques Reynes, (unknown), Jain Chung, Lucy Rowell, (unknown), A Bertasso, (unknown)	12
11	Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006) 2009 ·Critical Care Medicine ·Olivier Leroy, Jean‐Pierre Gangneux, Philippe Montravers, Jean‐Paul Mira, F. Gouin, Jean-Pierre Sollet, Jean Carlet, Jacques Reynes, M. Rosenheim, B. Régnier, Olivier Lortholary	397
12	Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data 2009 ·Journal of Antimicrobial Chemotherapy ·Camélia Protopopescu, F. Raffi, Perrine Roux, Jacques Reynes, P. Dellamonica, Bruno Spire, C. Leport, Patrizia Carrieri, (unknown)	87
13	Suppression of MicroRNA-Silencing Pathway by HIV-1 During Virus Replication breakdown → 2007 ·Science ·Robinson Triboulet, Bernard Mari, Yea‐Lih Lin, Christine Chable-Bessia, Yamina Bennasser, Kévin Lebrigand, Bruno Cardinaud, Thomas Maurin, Pascal Barbry, Vincent Baillat, Jacques Reynes, Pierre Corbeau, Kuan‐Teh Jeang, Monsef Benkirane	516
14	Qualité de vie et syndrome lipodystrophique chez les patients infectés par le VIH 2006 ·L Encéphale ·Marie Préau, Anne‐Déborah Bouhnik, Bruno Spire, C. Leport, Marianne Savès, O Picard, Jacques Reynes, Dominique Salmon, P. Dellamonica, F. Raffi, M. Morin, (unknown)	10
15	Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults? 2005 ·Journal of Infection ·Stéphanie Badiou, Corinne Merle De Boever, Nathalie Terrier, Vincent Baillat, Jean‐Paul Cristol, Jacques Reynes	29
16	Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures 2004 ·AIDS ·Christine Katlama, Stéphanie Dominguez, Karine Gourlain, Claudine Duvivier, Constance Delaugerre, (unknown), Roland Tubiana, Jacques Reynes, Jean‐Michel Molina, Gilles Peytavin, Vincent Cálvez, Dominique Costagliola	73
17	Risk Factors for Coronary Heart Disease in Patients Treated for Human Immunodeficiency Virus Infection Compared with the General Population 2003 ·Clinical Infectious Diseases ·Marianne Savès, Geneviève Chêne, Pierre Ducimetière, C. Leport, G. Le Moal, Philippe Amouyel, Dominique Arveiler, J.B. Ruidavets, Jacques Reynes, A. Bingham, F. Raffi, (unknown)	318
18	Leishmania-Human Immunodeficiency Virus Coinfection in the Mediterranean Basin: Isoenzymatic Characterization of 100 Isolates of the Leishmania infantum Complex 1995 ·The Journal of Infectious Diseases ·Francine Pratlong, Jean-Pierre Dedet, Pierre Marty, Montserrat Portús, M Deniau, J. Dereure, P. Abranches, Jacques Reynes, A. Martini, M. Lefèbvre, (unknown)	89
19	In-vitro synthesis of antibodies to Toxoplasma gondii by lymphocytes from HIV-1-infected patients 1993 ·The Lancet ·(unknown), (unknown), (unknown), (unknown), A Serre, Jacques Reynes, N. Atoui, Michel Segondy, Francine Pratlong	8
20	[Treatment and secondary prophylaxis with fluconazole for oropharyngeal candidiasis in HIV-positive patients. A mycological analysis of failures]. 1992 ·PubMed ·Jacques Reynes, M. Mallié, David Andre, F Janbon, J.-M. Bastide	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact